![](/img/cover-not-exists.png)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
Doebele, Robert C, Drilon, Alexander, Paz-Ares, Luis, Siena, Salvatore, Shaw, Alice T, Farago, Anna F, Blakely, Collin M, Seto, Takashi, Cho, Byung Chul, Tosi, Diego, Besse, Benjamin, Chawla, Sant P,Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(19)30691-6
Date:
December, 2019
File:
PDF, 1.24 MB
2019